期刊文献+

非洛地平对5/6肾大部分切除大鼠心肌细胞L型钙电流的影响 被引量:3

The effects of felodipine on L-type calcium channel of 5/6 subtotal nephrectomised rat cardiomyocytes
下载PDF
导出
摘要 目的 探讨非洛地平对 5 / 6肾大部分切除大鼠心肌细胞L型钙电流的影响。方法  5 / 6肾大部分切除手术制作肾功能衰竭大鼠模型 ,使用膜片钳全细胞记录技术记录心肌细胞L型钙电流。结果5 / 6肾切除大鼠心肌细胞L型钙电流明显增大 ,稳态失活曲线左移。非洛地平能够逆转L型钙电流的增大 ,但未能逆转通道失活性质的改变。结论 慢性肾衰竭可能引起心肌细胞钙操纵的改变 ,非洛地平可以逆转这种改变 ,还能促进L型钙离子通道的电压依赖性失活。 Objective To investigate the effects of felodipine on L-type calcium currents of rat cardiomyocytes after 5/6 subtotal nephrectomised. Method Animals were divided into three groups as follow: gorup A, 5/6 subtotal nephrectomy(SNx);group B, SNx administrated with 10mg/kg/d of felodipine;gorup C,control.Sprague-dawley rats underwent two-stage SNx; control rats underwent bilateral renal decapsulation. Animals were sacrificed after 12 weeks.Whole-cell patch clamp techniques were used to examine L-type calcium currents(ICa,L)in isolated cardiomyocytes. Results The amplitude of L-type calcium current significantly increased in SNx rats and was blocked by felodipine partly.The potential giving 50%of inactivation(V1/2) moved towards more negative in SNx rats than in control,and it had no change after administrated felodipine.Conclusions The calciumhandling of SNx rats cardiomyocytes changes.Felodipine can reverse this change of calcium handling partly and promote the voltage-dependent inactivation of L-type calcium channel.
出处 《中国血液净化》 2003年第9期493-496,共4页 Chinese Journal of Blood Purification
关键词 非洛地平 肾大部分切除 大鼠 心肌细胞 L型钙电流 肾功能衰竭 L-type calcium channel Cardiomyocytes 5/6 subtotal nephrectomy Felodipine Patch clamp
  • 相关文献

参考文献1

二级参考文献9

  • 1Paul D, Aisling C,McMahon, et al. L-type calcium current of isolated rat cardiac myocytes in experimental uraemia [J]. Nephrol Dial Transplant, 2000,15 (6): 791 - 798.
  • 2Paul D, Bruce M, Hendry, et al. An alterd repolarizing potassium current in rat cardiac myocyte after subtotal nephrectomy [ J ]. J Am Soc Nephrol, 2000, 11 (9): 1589 -1599.
  • 3Mitra R, Morad M. A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates[J]. Am J Physiol, 1985, 249:H1056 - 1060.
  • 4Tytgat J. How to isolate cardiac myocytes[J] . Cardiovasc Res, 1994, 28:280 - 283.
  • 5Isenberg G, Kloc ckner U. Calcium tolerant ventricular myocytes prepared by pre-incubation in a "KB" medium[J].Pflügers Arch, 1982, 395:6 - 18.
  • 6LiS, BlaschkeM, HeubachJF, etal. Effects of azelastine on contractility, action potentials and L-type Ca2+ current in guinea pig cardiac preparations [J]. Eur J Pharmacol,2001, 418:7 - 14.
  • 7Yazawa K, Kaibara M, Ohara M, et al. An improved method for isolating cardiac myocytes useful for patchclamp studies[J]. Jpn J Physiol, 1990, 40:157 - 163.
  • 8Satoh H, Sperelakis N. Review of some actions of taurine on ion channels of cardiac muscle cells ande other [J] . Gen Pharmacol, 1998,30(4): 451 - 463.
  • 9Thum T, Borlak J. Isolation and cultivation of Ca2 + tolerant cardiomyocytes from the adult rat: improvements and applications[J]. Xenobiotica, 2000, 30:1063 - 1077.

共引文献3

同被引文献40

  • 1谭若芸,赵卫红,王笑云,刘翠萍.T型钙通道α_(1G)亚单位在慢性肾衰竭大鼠左心室心肌中的表达及钙三醇干预的研究[J].中国血液净化,2005,4(1):5-9. 被引量:1
  • 2Gross ML,Ritz E.Hypertrophy and fibrosis in the cardiomyopathy of uremia-beyond coronary heart disease[J].Semin Dial,2008,21:308-318.
  • 3Remppis A,Ritz E.Cardiac problems in the dialysis patient:beyond coronary disease[J].Semin Dial,2008,21:319-325.
  • 4Parekh RS,Plantinga LC,Kao WH,et al.The association of sudden cardiac death with inflammztion and other traditional risk factors[J].Kidney Int.2008,74:1335-1342.
  • 5Wen CP,Cheng TY,Tsai MK,et al.All-cause mortality attributable to chronic kidney ditease:a prospective cohort study based on 462 293 adults in Taiwan[J].Lancet,2008,371:2173-2182.
  • 6Dellegrottaglie S,Saran R,Gillespie B,et al.Prevalence and predictors of cardiovascular calcium in chronic kidney disease(from the Prospective Longitudinal RRI-CKD Study)[J].Am J Cardiol,2006,98:571-576.
  • 7Tyral la K,Amann K.Cardiovascular changes in renal failure[J].Blood Purif,2002,20:462-465.
  • 8Foley RN,Parfrey PS,Harnett JD,et al.Clinical and echocardiographic disease in patients starting end-stage renal disease therapy[J].Kidney Int,1995,47:186-192.
  • 9Ulasi,II,Arodiwe EB,Ijoma CK.Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation[J].Ethn Dis,2006,16:859-864.
  • 10Drittanti L,de Boland AR,Boland R.Changes in muscle lipid metabolism induced in vitro by 1,25-dihydroxy-vitamin D-3[J].Biochim Biophys Acta,1987,918:83-92.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部